Part Details | THEOPHYLLINE EXTENDED-RELEASE CAPSULES
6505-01-173-1906
Alternate Parts: SLOBID GYROCAPS, SLO-BID GYROCAPS, SLOBID, SLO-BID, NDC00075020099, NDC00075-0200-99, NDC00258363401, NDC00258-3634-01, NDC00603595121, NDC00603-5951-21, NDC00258363401, NDC00258-3634-01, 6505-01-173-1906, 01-173-1906, 6505011731906, 011731906
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAR 03, 1984 | 01-173-1906 | 42774 ( THEOPHYLLINE EXTENDED-RELEASE CAPSULES ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-173-1906
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| SLO-BID GYROCAPS | 04518 | AVENTIS PHARMACEUTICALS PRODUCTSINC. |
| SLO-BID | 04518 | AVENTIS PHARMACEUTICALS PRODUCTSINC. |
| NDC00075-0200-99 | 04518 | AVENTIS PHARMACEUTICALS PRODUCTSINC. |
| NDC00258-3634-01 | 65050 | FOREST PHARMACEUTICALS INCSUB OF FOREST LABORATORIES INC |
| NDC00603-5951-21 | 0ET99 | GENERICS BIDCO I, LLCDBA PAR PHARMACEUTICAL |
| NDC00258-3634-01 | 6X308 | INWOOD LABORATORIES INC |
Technical Data | NSN 6505-01-173-1906
| Characteristic | Specifications |
|---|---|
| CAPSULE TYPE | |
| CAPSULE CONTENT FORM | |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB200.000 MILLIGRAMS THEOPHYLLINE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 1000.000 |
| THERAPEUTIC EQUIVALENT | SLO-BID GYROCAPS BY RORER PHARMACEUTICAL |
| SPECIAL FEATURES | ANHYDROUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 200MG 1000S BT |